Market revenue in 2023 | USD 655.5 million |
Market revenue in 2030 | USD 1,212.4 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 57.01% in 2023. Horizon Databook has segmented the North America deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
The rising prevalence of movement and psychiatric disorders coupled with increasing geriatric population in the region. For instance, according to Parkinson's Foundation (PF), symptoms of Parkinson's Disease (PD) are common at an average age of 60.
The geriatric population is highly susceptible to these disorders. In addition, increase in government funding and initiatives for raising awareness about movement disorders is expected to drive the demand for deep brain stimulation devices in the region.
This approval will expand treatment options for more than one million patients suffering from seizures and do not respond to medication in the U.S. These factors are expected to boost the demand for deep brain stimulation devices in this region.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account